| Primary |
| Rheumatoid Arthritis |
31.1% |
| Myocardial Ischaemia |
9.3% |
| Back Pain |
7.5% |
| Hypertension |
7.5% |
| Intervertebral Disc Disorder |
5.6% |
| Osteoporosis |
5.6% |
| Spinal Osteoarthritis |
4.3% |
| Hyperlipidaemia |
3.7% |
| Arthralgia |
2.5% |
| Gastric Ulcer |
2.5% |
| Gastritis |
2.5% |
| Insomnia |
2.5% |
| Lumbar Spinal Stenosis |
2.5% |
| Osteoarthritis |
2.5% |
| Pain In Extremity |
2.5% |
| Allergy Test |
1.9% |
| Nasopharyngitis |
1.9% |
| Reflux Oesophagitis |
1.9% |
| Analgesic Therapy |
1.2% |
| Gastric Mucosal Lesion |
1.2% |
|
| Drug Eruption |
11.3% |
| Interstitial Lung Disease |
11.3% |
| Hepatorenal Syndrome |
7.5% |
| Liver Disorder |
7.5% |
| Diverticulum Intestinal Haemorrhagic |
5.7% |
| Haematemesis |
5.7% |
| Stevens-johnson Syndrome |
5.7% |
| Analgesic Asthma Syndrome |
3.8% |
| Colitis Ulcerative |
3.8% |
| Death |
3.8% |
| Melaena |
3.8% |
| Peritonitis |
3.8% |
| Platelet Count Decreased |
3.8% |
| Pleural Effusion |
3.8% |
| Rash Generalised |
3.8% |
| Septic Shock |
3.8% |
| Ulcer Haemorrhage |
3.8% |
| Vomiting |
3.8% |
| Alveolitis Allergic |
1.9% |
| Angina Pectoris |
1.9% |
|
| Secondary |
| Rheumatoid Arthritis |
40.7% |
| Prophylaxis |
8.9% |
| Drug Use For Unknown Indication |
5.6% |
| Hypertension |
4.2% |
| Back Pain |
4.0% |
| Multiple Myeloma |
3.9% |
| Osteoporosis |
3.9% |
| Gastritis |
3.3% |
| Cataract |
3.2% |
| Sciatica |
3.2% |
| Cancer Pain |
2.6% |
| Pain |
2.5% |
| Parkinson's Disease |
2.1% |
| Arthralgia |
1.8% |
| Gastric Ulcer |
1.8% |
| Osteoarthritis |
1.8% |
| Postoperative Care |
1.8% |
| Upper Respiratory Tract Inflammation |
1.8% |
| Constipation |
1.6% |
| Gastrointestinal Disorder Therapy |
1.6% |
|
| Sepsis |
13.1% |
| Disseminated Tuberculosis |
9.5% |
| White Blood Cell Count Increased |
8.3% |
| Pulmonary Tuberculosis |
6.0% |
| Pyrexia |
6.0% |
| Stevens-johnson Syndrome |
6.0% |
| White Blood Cell Count Decreased |
6.0% |
| Hepatorenal Syndrome |
4.8% |
| Ileus |
4.8% |
| Rash |
4.8% |
| Renal Disorder |
4.8% |
| Renal Failure Acute |
3.6% |
| Staphylococcal Infection |
3.6% |
| Stomach Discomfort |
3.6% |
| Swelling Face |
3.6% |
| Anaemia |
2.4% |
| Convulsion |
2.4% |
| Dizziness |
2.4% |
| Haemoglobin Decreased |
2.4% |
| Malaise |
2.4% |
|
| Concomitant |
| Rheumatoid Arthritis |
31.2% |
| Prophylaxis |
7.5% |
| Cancer Pain |
7.0% |
| Pain |
5.8% |
| Hypertension |
5.1% |
| Drug Use For Unknown Indication |
4.9% |
| Product Used For Unknown Indication |
4.3% |
| Metastatic Renal Cell Carcinoma |
4.2% |
| Osteoporosis |
3.5% |
| Constipation |
3.5% |
| Gastritis |
2.8% |
| Insomnia |
2.8% |
| Metastases To Bone |
2.8% |
| Multiple Myeloma |
2.7% |
| Renal Cell Carcinoma |
2.7% |
| Breast Cancer |
2.1% |
| Premedication |
2.0% |
| Prostate Cancer |
1.9% |
| Gastric Ulcer |
1.7% |
| Back Pain |
1.5% |
|
| Pyrexia |
8.7% |
| Vomiting |
8.1% |
| Interstitial Lung Disease |
7.8% |
| White Blood Cell Count Decreased |
7.8% |
| Stomatitis |
7.4% |
| Pneumocystis Jiroveci Pneumonia |
7.1% |
| Pulmonary Tuberculosis |
6.1% |
| Rash |
5.5% |
| White Blood Cell Count Increased |
5.5% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
4.2% |
| Pneumonia |
4.2% |
| Respiratory Failure |
3.6% |
| Platelet Count Decreased |
3.2% |
| Renal Cell Carcinoma |
3.2% |
| Renal Impairment |
3.2% |
| Somnolence |
3.2% |
| Urinary Tract Infection |
3.2% |
| Cerebral Haemorrhage |
2.6% |
| Malignant Neoplasm Progression |
2.6% |
| Tuberculosis |
2.6% |
|
| Interacting |
| Hypertension |
53.8% |
| Pain |
46.2% |
|
|